
Itorax OD 150mg Capsule SR
Marketer
Tas Med India Pvt Ltd
Salt Composition
Itopride (150mg)
Overview Itorax OD 150mg Capsule SR
Domperix SR 150mg capsules are a prescription medication prescribed to alleviate nausea and vomiting, and to mitigate postprandial fullness. This medicine also addresses stomach discomfort and heartburn stemming from sluggish gastrointestinal function. Domperix SR 150mg capsules are administered before meals, with dosage and treatment length determined by your physician. Your prescribed dose will be tailored to your individual needs and response. Continue taking this medication until your doctor instructs otherwise. Inform your doctor of all other medications you're currently using, as interactions are possible. The most frequently reported side effects are diarrhea and abdominal pain, typically transient and resolving spontaneously. However, consult your physician if you have any concerns. Dizziness and drowsiness may also occur; avoid driving or activities demanding concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential exacerbation of sleepiness. Since diarrhea is a possibility, increased fluid intake is recommended to prevent dehydration. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical counsel.
Uses of Itorax OD 150mg Capsule SR
Managing Acid Reflux and Queasiness
Major Benefits of Itorax OD 150mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Itorax OD 150mg Capsule SR whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Itorax OD 150mg Capsule SR:
- Diarrhea
How to use Itorax OD 150mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Itorax OD 150mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Itorax OD 150mg Capsule SR works:
Itorax OD 150mg Sustained-Release Capsules stimulate gastrointestinal motility. This prokinetic agent targets the brain's emetic center, suppressing nausea and vomiting. Simultaneously, it enhances upper gastrointestinal tract peristalsis, facilitating efficient food passage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Itorax OD 150mg SR capsules is not advised without first seeking medical counsel. A physician should be consulted.
PregnancyCONSULT YOUR DOCTOR
Data on Itorax OD 150mg SR capsules and pregnancy are currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Itorax 150mg capsules are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Itorax OD 150mg SR Capsules on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Itorax OD 150mg sustained-release capsules to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Itorax OD 150mg sustained-release capsules' use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Itorax OD 150mg Capsule SR :
Should you forget to take a Itorax OD 150mg sustained-release capsule, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Itorax OD 150mg Capsule SR
| Label | Value |
|---|---|
| Chemical Type | Benzamide analog |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Prokinetic agent with dopamine (D2) receptor antagonism |
